These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 33550691)

  • 1. Metformin as a potential protective therapy against tuberculosis in patients with diabetes mellitus: A retrospective cohort study in a single teaching hospital.
    Fu CP; Lee CL; Li YH; Lin SY
    J Diabetes Investig; 2021 Sep; 12(9):1603-1609. PubMed ID: 33550691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of metformin use among tuberculosis close contacts with diabetes mellitus in a nationwide cohort study.
    Lee MC; Lee CH; Lee MR; Wang JY; Chen SM
    BMC Infect Dis; 2019 Nov; 19(1):936. PubMed ID: 31694558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity.
    Komosinska-Vassev K; Gala O; Olczyk K; Jura-Półtorak A; Olczyk P
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32917052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin use is associated with a low risk of tuberculosis among newly diagnosed diabetes mellitus patients with normal renal function: A nationwide cohort study with validated diagnostic criteria.
    Lee MC; Chiang CY; Lee CH; Ho CM; Chang CH; Wang JY; Chen SM
    PLoS One; 2018; 13(10):e0205807. PubMed ID: 30335800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cumulative dose-dependent effects of metformin on the development of tuberculosis in patients newly diagnosed with type 2 diabetes mellitus.
    Heo E; Kim E; Jang EJ; Lee CH
    BMC Pulm Med; 2021 Sep; 21(1):303. PubMed ID: 34563159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of metformin against tuberculosis infections in diabetic patients: an observational study of south Indian tertiary healthcare facility.
    Marupuru S; Senapati P; Pathadka S; Miraj SS; Unnikrishnan MK; Manu MK
    Braz J Infect Dis; 2017; 21(3):312-316. PubMed ID: 28199824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy.
    Kumar NP; Moideen K; Nancy A; Viswanathan V; Shruthi BS; Sivakumar S; Hissar S; Kornfeld H; Babu S
    BMC Infect Dis; 2019 Dec; 19(1):1039. PubMed ID: 31818258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin Use Reverses the Increased Mortality Associated With Diabetes Mellitus During Tuberculosis Treatment.
    Degner NR; Wang JY; Golub JE; Karakousis PC
    Clin Infect Dis; 2018 Jan; 66(2):198-205. PubMed ID: 29325084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slow radiological improvement and persistent low-grade inflammation after chemotherapy in tuberculosis patients with type 2 diabetes.
    Mily A; Sarker P; Taznin I; Hossain D; Haq MA; Kamal SMM; Agerberth B; Brighenti S; Raqib R
    BMC Infect Dis; 2020 Dec; 20(1):933. PubMed ID: 33287713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin promotes smear conversion in tuberculosis-diabetes comorbidity and construction of prediction models.
    Wang Y; Zhou Y; Chen L; Cheng Y; Lai H; Lyu M; Zeng J; Zhang Y; Feng P; Ying B
    J Clin Lab Anal; 2022 Dec; 36(12):e24755. PubMed ID: 36347820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal function markers and metformin eligibility.
    Tavares Bello C; Castro Fonseca R; Sousa Santos F; Sequeira Duarte J; Azinheira J; Vasconcelos C
    Minerva Endocrinol; 2018 Sep; 43(3):246-252. PubMed ID: 28565889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.
    Brocco E; Velussi M; Cernigoi AM; Abaterusso C; Bruseghin M; Carraro A; Sambataro M; Piarulli F; Sfriso A; Nosadini R
    J Nephrol; 2001; 14(6):461-71. PubMed ID: 11783602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fixed-dose combination associated with faster time to smear conversion compared to separate tablets of anti-tuberculosis drugs in patients with poorly controlled diabetes and pulmonary tuberculosis in Qatar.
    Al-Shaer MH; Elewa H; Alkabab Y; Nazer LH; Heysell SK
    BMC Infect Dis; 2018 Aug; 18(1):384. PubMed ID: 30089476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of metformin on culture conversion in tuberculosis patients with diabetes mellitus.
    Lee YJ; Han SK; Park JH; Lee JK; Kim DK; Chung HS; Heo EY
    Korean J Intern Med; 2018 Sep; 33(5):933-940. PubMed ID: 29540054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term metformin use and risk of pneumonia and related death in type 2 diabetes: a registry-based cohort study.
    Yang A; Shi M; Wu H; Lau ESH; Ma RCW; Kong APS; So WY; Luk AOY; Chan JCN; Chow E
    Diabetologia; 2021 Aug; 64(8):1760-1765. PubMed ID: 33844069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Geroprotective Effects of Metformin and Risk of Open-Angle Glaucoma in Persons With Diabetes Mellitus.
    Lin HC; Stein JD; Nan B; Childers D; Newman-Casey PA; Thompson DA; Richards JE
    JAMA Ophthalmol; 2015 Aug; 133(8):915-23. PubMed ID: 26022641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes mellitus is associated with cavities, smear grade, and multidrug-resistant tuberculosis in Georgia.
    Magee MJ; Kempker RR; Kipiani M; Gandhi NR; Darchia L; Tukvadze N; Howards PP; Narayan KM; Blumberg HM
    Int J Tuberc Lung Dis; 2015 Jun; 19(6):685-92. PubMed ID: 25946360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The short-term effect of a switch from glibenclamide to metformin on blood pressure and microalbuminuria in patients with type 2 diabetes mellitus.
    Amador-Licona N; Guízar-Mendoza J; Vargas E; Sánchez-Camargo G; Zamora-Mata L
    Arch Med Res; 2000; 31(6):571-5. PubMed ID: 11257323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Effectiveness of Second-Line Agents for the Treatment of Diabetes Type 2 in Preventing Kidney Function Decline.
    Hung AM; Roumie CL; Greevy RA; Grijalva CG; Liu X; Murff HJ; Ikizler TA; Griffin MR
    Clin J Am Soc Nephrol; 2016 Dec; 11(12):2177-2185. PubMed ID: 27827311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.
    Derosa G; Cicero AF; Gaddi AV; Ciccarelli L; Piccinni MN; Salvadeo S; Pricolo F; Fogari E; Ghelfi M; Ferrari I; Fogari R
    Clin Ther; 2005 Sep; 27(9):1383-91. PubMed ID: 16291411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.